European survey of the level of satisfaction of patients and physicians in the management of epilepsy in general practice

Epilepsy and Behavior

Volumn 19, Issue 1, 2010, Pages 36-42

  Ross, John ^a   Stefan, Hermann ^b   Schäuble, Barbara ^c   Day, Richard ^a   Sander, Josemir W ^d  

^a Richard Day Research   (United States)

^b UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^c JANSSEN CILAG GMBH   (Germany)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Adverse effects; Antiepileptic drugs; Epilepsy; Quality of life; Seizure control; Survey

Indexed keywords

ANTICONVULSIVE AGENT;

ADULT; ADVERSE OUTCOME; ANXIETY; ARTICLE; BEHAVIOR CHANGE; COGNITIVE DEFECT; DEPRESSION; DISEASE CONTROL; DOCTOR PATIENT RELATION; EPILEPSY; EUROPE; FEMALE; GENERAL PRACTICE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT SATISFACTION; PHYSICIAN ATTITUDE; QUALITY OF LIFE; QUESTIONNAIRE; SELF CARE; SIDE EFFECT;

ANTICONVULSANTS; EPILEPSY; EUROPE; FAMILY PRACTICE; FEMALE; HEALTH SURVEYS; HUMANS; MALE; PATIENT COMPLIANCE; PATIENT SATISFACTION; PHYSICIANS; PUBLIC HEALTH; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 77956614333     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2010.06.002     Document Type: Article

References (22)

1. Duncan J.S., Sander J.W., Sisodiya S.M., Walker M.C. Adult epilepsy. Lancet 2006, 367:1087-1100.
2. Heaney D.C., Sander J.W. Antiepileptic drugs: generic versus branded treatments. Lancet Neurol 2007, 6:465-468.
3. Sander J.W. Ultimate success in epilepsy: the patient's perspective. Eur J Neurol 2005, 12(Suppl. 4):3-11.
4. St Louis E.K. Minimizing AED adverse effects: improving quality of life in the interictal state in epilepsy care. Curr Neuropharmacol 2009, 7:106-114.
5. Perucca P., Carter J., Vahle V., Gilliam F.G. Adverse antiepileptic drug effects: toward a clinically and neurobiologically relevant taxonomy. Neurology 2009, 72:1223-1229.
6. Fisher R.S., Vickrey B.G., Gibson P., et al. The impact of epilepsy from the patient's perspective: II. Views about therapy and health care. Epilepsy Res 2000, 41:53-61.
7. Jacoby A., Snape D., Baker G.A. Determinants of quality of life in people with epilepsy. Neurol Clin 2009, 27:843-863.
8. Sherman E.M. Maximizing quality of life in people living with epilepsy. Can J Neurol Sci 2009, 36(Suppl. 2):S17-S24.
9. Suurmeijer T.P.B.M., Reuvekamp M.F., Aldenkamp B.P. Social functioning, psychological functioning and quality of life in epilepsy. Epilepsia 2001, 42:1160-1168.
10. Rothwell P.M., McDowell Z., Wong C.K., Dorman P.J. Doctors and patients don't agree: cross sectional study of patients' and doctors' perceptions and assessments of disability in multiple sclerosis. Br Med J 1997, 314:1580-1583.
11. Coghill D., Soutullo C.A., d'Aubuisson C., et al. Impact of attention-deficit/hyperactivity disorder on the patient and family: results from a European survey. Child Adolesc Psychiatry Ment Health 2008, 2:31.
12. Mula M., Viana M., Jauch R., et al. Health-related quality of life measures and psychiatric comorbidity in patients with migraine. Eur J Neurol 2009, 16:1017-1021.
13. Susman E. AES: Defective communication seen between physicians and epilepsy patients. Available at: http://www.medpagetoday.com/Neurology/Seizures/7566. Accessed: 17 February 2010.
14. American Healthways. Defining the patient-physician relationship for the 21st century. In: 3rd Annual Disease Management Outcomes Summit; October 30-November 2, 2003; Phoenix, AZ. Available at: http://www.patient-physician.com/docs/PatientPhysician.pdf. Accessed: 18 December 2009.
15. Pugh M.J., Berlowitz D.R., Montouris G., et al. What constitutes high quality of care for adults with epilepsy?. Neurology 2007, 69:2020-2027.
16. Baker G.A., Jacoby A., Buck D., Stalgis C., Monnett D. Quality of life of people with epilepsy: a European study. Epilepsia 1997, 38:353-362.
17. Mattson R.M., Cramer J.A., Collins J.F., et al. Comparison of phenobarbital, phenytoin, carbamazepine and primidone in partial and secondary generalized tonic-clonic seizures. N Engl J Med 1985, 313:145-151.
18. Gillam F.G., Fessler A.J., Baker G., Vahle V., Carter J., Ararian H. Systematic screening allows reduction of adverse antiepileptic drug effects: a randomized trial. Neurology 2004, 62:23-27.
19. Hovinga C.A., Asato M.R., Manjunath R., et al. Association of non-adherence to antiepileptic drugs and seizures, quality of life, and productivity: survey of patients with epilepsy and physicians. Epilepsy Behav 2008, 13:316-322.
20. St Louis E.K., Rosenfeld W.E., Bramley T. Antiepileptic drug monotherapy: the initial approach in epilepsy management. Curr Neuropharmacol 2009, 7:77-82.
21. Kilinç S., Campbell C. "It shouldn't be something that's evil, it should be talked about": a phenomenological approach to epilepsy and stigma. Seizure 2009, 18:665-671.
22. Bandstra N.F., Camfield C.S., Camfield P.R. Stigma of epilepsy. Can J Neurol Sci 2008, 35:436-440.